<DOC>
	<DOC>NCT01103726</DOC>
	<brief_summary>We hypothesize that PF-02545920 will increase glucose metabolism in a part of the brain called the striatum.</brief_summary>
	<brief_title>Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy righthanded male and female subjects between the ages of 18 and 55 years, inclusive Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg (110 lbs) An informed consent document signed and dated by the subject Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures Women of reproductive potential History of agranulocytosis or movement disorder Positron Emission Tomography (PET) or Magnetic Resonance Imaging (MRI) contraindications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>FDG-PET</keyword>
	<keyword>regional cerebral glucose metabolism</keyword>
	<keyword>striatum</keyword>
	<keyword>PDE10 inhibitor</keyword>
</DOC>